Alventa Pharma Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials and compliance.
CIN U24299WB2016PLC225674 Incorporated 28 October 2016 ROC Kolkata HQ Kolkata, West Bengal, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹142.72 Cr
▲ 82.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹35.05 Lakh
Issued & subscribed
Open charges
₹30 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Last financials
Mar 2025
Balance sheet date

About Alventa Pharma Limited

Data last updated: 06 January 2026

Alventa Pharma Limited is a public limited company based in Kolkata, West Bengal, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 October 2016, the company has been in operation for over 10 years.

Registered with ROC Kolkata under CIN U24299UP2016PTC087395.

Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹35.05 Lakh. Formerly known as Elder Labs Private Limited. It is led by directors including Anand Kumar Parmanandka and Rubi Mukhopadhyay.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Kolkata, West Bengal.

As per the financials filed for FY 2025, the company reported a revenue of ₹142.72 Cr, a growth of 82% compared to the previous year.

The company is associated with 1 brand - Alventa Pharma. As per MCA filings, the company has open charges of ₹30 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alventapharma.com.

Company Details of Alventa Pharma Limited
CIN U24299WB2016PLC225674
Registration Number 225674
Incorporation Date 28 October 2016
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Room No.79 & 80 3Rd Floor, At 55 Biplabi Rash Behari Basu Road (Mehta Building), Kolkata, West Bengal, India – 700001
  • Industry
    Pharma, Drug Formulation & Development
Company report
Alventa Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Alventa Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Alventa Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Alventa Pharma Limited

Alventa Pharma Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24299WB2016PLC225674, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24299WB2016PLC225674 Current
U24299UP2016PTC087395 Previous
U24299WB2016PTC225674 Previous

Associated Brands with Alventa Pharma Limited

Alventa Pharma Limited operates one associated brand: Alventa Pharma. These brands represent Alventa Pharma Limited's diversified market presence and brand portfolio.

Brand Description Website
Develops and manufactures generic drugs, offers CDMO services, and exports pharmaceuticals globally. alventapharma.com

Competitors & Alternatives of Alventa Pharma Limited

Brands and companies operating in the same space as Alventa Pharma Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Kezzler Kezzler Mass serialization solutions for a wide range of industries Oslo, Norway, Norway 2001
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006

Business Activity of Alventa Pharma Limited

Alventa Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Alventa Pharma Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Alventa Pharma Limited

Alventa Pharma Limited is currently managed by 3 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Anand Kumar Parmanandka Additional Director 29 Apr 2018 8 Years 2 Months Current
Rubi Mukhopadhyay Director 04 Jun 2018 8 Years 1 Months Current
Biswajit Pan Director 07 Jun 2019 7 Years 1 Months Current

Financials of Alventa Pharma Limited FY 2025 filings available

Alventa Pharma Limited reported revenue of ₹142.72 Cr (up 82.00% YoY) for FY 2025.

Revenue · FY 2025
₹142.72 Cr ▲ 82.00%
Premium access

Ten-year financial statements for Alventa Pharma Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Alventa Pharma Limited

Open charges
₹30 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹20.00 Cr
Indian Bank₹10.00 Cr
Latest charge details
DateLenderAmountStatus
04 Nov 2025 Others ₹20 Cr Open
22 Dec 2023 Indian Bank ₹10 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Alventa Pharma Limited

View historical data on people associated with Alventa Pharma Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Alventa Pharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Alventa Pharma Limited

Premium access

GST registrations and filing compliance for Alventa Pharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Alventa Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Alventa Pharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Alventa Pharma Limited

Premium access

MSME payment history for Alventa Pharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Alventa Pharma Limited

Premium access

Corporate group structure for Alventa Pharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Alventa Pharma Limited

Premium access

MCA filings and documents for Alventa Pharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Alventa Pharma Limited

Charges
04 Nov 2025
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101189989 was registered on 04 Nov 2025.
Activity
29 Sep 2025
Alventa Pharma Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Alventa Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
22 Dec 2023
A charge with Indian Bank amounted to Rs. 10.00 Cr with Charge ID 100833805 was registered on 22 Dec 2023.
Directors
07 Jun 2019
Biswajit Pan was appointed as a Director on 07 Jun 2019 & has been associated with this company since 7 years 1 month.
Directors
04 Jun 2018
Rubi Mukhopadhyay was appointed as a Director on 04 Jun 2018 & has been associated with this company since 8 years 1 month.

Recent News on Alventa Pharma Limited

Frequently Asked Questions about Alventa Pharma Limited

Alventa Pharma Limited is an active public limited company in the pharma sector based in Kolkata, West Bengal, India. It was incorporated on 28 October 2016 (10+ years old) and is registered under CIN U24299WB2016PLC225674.

Alventa Pharma Limited reported revenue of ₹142.72 Cr for FY 2025 (up 82.00% YoY).

The current directors of Alventa Pharma Limited are:

The primary industry of Alventa Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Alventa Pharma Limited can be reached at the registered office: Room No.79 & 80 3Rd Floor, At 55 Biplabi Rash Behari Basu Road Mehta Building, Kolkata, West Bengal, India – 700001, or through the website alventapharma.com.

The authorised capital is ₹2 Cr, and the paid-up capital is ₹35.05 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available